The average P/S ratio for SWTX's competitors is 259.40, providing a benchmark for relative valuation. SpringWorks Therapeutics Inc Corp (SWTX) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 133.68%, this premium appears sustainable.